CRYSTAL PEEL
Testo originale in francese.
Prodotto naturale per la salute autorizzato in Canada
- Altri nomi
- Superficial Chemical Peel
- Titolare
- 2625686 ONTARIO INC dba NUVIOR
- NPN o DIN-HM
- 80124648
- Stato
- Licenza attiva
- Data della licenza
- 25 maggio 2023
- Data di revisione
- Non indicata
- Forma
- Liquide topique
- Via di somministrazione
- Topique
- Tipo di domanda
- Générale (non traditionelle)
L’analisi delle dosi orali non si applica senza una via esclusivamente orale accertata.
Composizione
| Ingrediente medicinale e fonte | Per unità posologica, secondo la fonte |
|---|---|
| Acide 2-hydroxybenzoïque Fonte : Acide salicylique | 20 % (v/v) |
Ingredienti non medicinali
Acide phosphorique, Eau, SD alcool 40-A
Dosi raccomandate in Canada
| Popolazione | Età | Quantità per assunzione | Frequenza |
|---|---|---|---|
| Adultes | minimum : 18 ans | Non précisée | Non précisée |
Usi autorizzati in Canada
Acne treatment. Intended for the treatment of Mild Acne & Hyperkeratosis. Intended for the treatment of Melasma, solar and senile lentigines and post inflammatory pigmentation.
Testo originale in inglese.
Un uso autorizzato in Canada non è un’indicazione sulla salute autorizzata nell’Unione europea. Consulti il registro delle indicazioni sulla salute.
Avvertenze in Canada
Known Adverse Reactions : Allergy alert get medical help right away if the patient develops hives, swelling of eyes and mouth, blistering, or difficulty breathing. Stop use if patient develops severe irritation, burning/itching of the skin, pigmentation, or milia. Use with caution in patients who have a recent history of smoking, herpes simplex, dermatitis, psoriasis, or any other inflammatory condition in the skin area to be treated Use with caution in patients who suffer from immunosuppression, or are taking oral contraceptives or tetracyclines Use with caution in patients who have recently had medical or cosmetic treatment or procedure (e.g., laser therapy, surgical procedures, cosmetic filler, microdermabrasion, etc.) Do not use on inflamed, broken or infected skin. Do not use in patients with vitiligo, diabetes, active cold sores, or poor blood circulation, or who currently suffer from any type of infection Do not apply to large areas of the body. Do not apply under occlusion (as this may cause salicylism, characterized by tinnitus, dizziness, abdominal cramps, and deafness) Do not use if patient is allergic to acetylsalicylic acid or other salicylates.
Testo originale in inglese.
Cautions and Warnings : For external use only. Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away. When using this product skin irritation and dryness are more likely to occur when using another topical acne product at the same time. If irritation occurs, use only one product at a time. When using this product, avoid contact with eyes. If contact occurs, rinse thoroughly with water. Avoid contact with mucous membranes such as nose and lips; protect these sensitive areas with a moisturizer or petrolatum-based agent. In case of contact, rinse thoroughly with water. If irritation persists, discontinue use and seek medical attention. Do not use on an irritated area, facial herpes, skin allergy or after taking retinoids (or any potentially irritating substance), eye contour and perioral area. Consult a health care practitioner if symptoms persist or worsen. Skin contact should be of limited frequency and duration. One week before the treatment, do not perform hair removal or electrolysis on the area to be treated. Four hours before the treatment, do not shave the affected area. The use of depilatory agents, waxes, depilatory lasers, exfoliating sponges and masks must be discontinued one week before the treatment. For Professional use only. Not for Retail Sale. Please limit sun exposure and apply a sunburn protectant for a week after using this product
Testo originale in inglese.
Contra-Indications : Do not use in patients who are pregnant or breastfeeding. Use with caution in patients who have HIV or have undergone treatment with dermabrasion or ablative resurfacing within the past 12 months. Do not use if the patient suffers from flat warts, or from a viral dermatological infection such as molloscum contagiosum. Do not use in patients who have taken isotretinoin in the past 12 months, have received recent chemotherapy or radiation therapy, or are taking photosensitizing medication. These side effects are frequently observed: burning, dermatitis, blisters, redness, swelling, itching, peeling, rash, dryness and skin lesions.
Testo originale in inglese.
Fonte
Scheda ufficiale Health Canada, licenza 80124648
Banca dati dei prodotti naturali per la salute autorizzati (BDPSNH), Health Canada: prodotti autorizzati, ingredienti, dosi, usi e avvertenze, consultato il 27 ottobre 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Testo originale in inglese.
Testo originale in francese.
La formula venduta in Europa con lo stesso nome può essere diversa. Queste informazioni non sostituiscono il parere di un medico o farmacista.
La data della prova di questo elenco di ingredienti è sconosciuta.
Il prodotto è cambiato? Fotografi la confezione.
Un'informazione inesatta o più recente su questo prodotto, che lei sia lettore o marca? Scriva a contact@compoatlas.com: ogni correzione è pubblicata nel registro delle correzioni.